Galexxy Holdings, Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Michael Biagi
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 4630 Campus Drive Newport Beach CA United States of America 92660
- IPO Date
- Mar 21, 2013
- CIK
- 0001481585
- Website
- galexxyholdings.com
- Similar Companies
- Business
- Galexxy Holdings, Inc. operates as a health and wellness company primarily engaged in the development, manufacturing, and marketing of functional mushroom-based products and adaptogens. Its core product portfolio includes a variety of functional mushroom supplements aimed at promoting health and wellness, leveraging mushroom isolates and blends for cognitive, immune, and overall well-being support. The company also extends into the hemp CBD oils and isolate industry through its former holdings but has recently divested those operations to focus exclusively on its mushroom and adaptogen business segments. Galexxy Holdings markets its products primarily in the United States with ongoing expansion efforts into blockchain-powered wellness marketplaces abroad. The company was founded in 2000 and is headquartered in Newport Beach, California. Recent major changes include the acquisition of WellBeing Farms LLC, which strengthens its production capabilities and product offerings in the functional mushroom sector. In May 2024, Galexxy formalized a pivotal Product and Brand Purchase Agreement consolidating full ownership of its mushroom-based product intellectual property, transitioning away from its CBD and hemp business. It also established a strategic partnership with New Age Marketing that enabled access to high-value business connections and facilitated an initial order from The Well Collective, a blockchain-enabled wellness marketplace, marking a significant step in its global digital platform expansion. In 2024, the company launched Adaptin, LLC, a new entity focused on adaptogen products, with an aligned vision to innovate in the wellness market through omnichannel distribution and community engagement strategies. These strategic moves reflect Galexxy’s shift toward specializing in mushroom-derived health solutions with a technology-enabled retail approach. Galexxy operates within the agricultural products and food, beverage, and tobacco industry sectors, targeting health-conscious consumers seeking natural wellness supplements. Its operations emphasize innovation in functional mushroom supplements distributed through direct sales, online platforms, and strategic partnerships. The company maintains a lean organizational structure with key executives including CEO Michael Biagi and President George T. Roth. Galexxy Holdings trades on the OTC Pink Sheets under the ticker symbol GXXY and continues to pursue growth opportunities in the expanding health and wellness industry.
GALEXXY HOLDINGS' New Age Marketing Partnership Delivers Sales from The Well Collective
Announcing Adaptin - Bringing Mushrooms to the Masses
Tyler Whitehead to Join Galexxy Holdings Inc.'s Board of Directors
Galexxy Holdings Inc. Announces New Company with Tyler Whitehead as CEO and Co-Founder
Galexxy Holdings Announces Strategic Decision to Divest CBD and Hemp and Expand its Functional Mushroom Businesses
Galexxy Inks an Agreement to Integrate Hussle's Leading Technology into Galexxy's New APP for Rapid Business Growth
Successful Business Executive Joins Galexxy Holdings' Management Team to Drive Market Growth
Galexxy's VendGenie(TM) to Expand Revenues to $12.75M in Smart Kiosks and Products with Delta 88 Agreement
Galexxy Holdings' Revenue Growth Strategy
Galexxy Holdings Signs Joint Venture with Pillars International, Bringing Two Firsts to the Direct Sales Industry